Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585676 · ClinicalTrials.gov registry record
Impact of Antenatal Betamethasone on Plasma Glucose Levels
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 45
- Enrollment target
NCT00585676: Completed study, sponsored by University of California, Irvine.
NCT00585676 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00585676 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
It is known that administration of steroids increases blood sugar levels. Administration of betamethasone is common practice during pregnancy to women at risk for preterm delivery. However, it is unknown the magnitude of the changes in glucose these women have after receiving betamethasone. The purpose of this study is to determine the magnitude and timing of the increase in blood sugar in pregnant women without diabetes who receive steroids.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-05 |
What the finished NCT00585676 record still lists
NCT00585676 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00585676 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00585676 about?
NCT00585676 is a clinical study titled "Impact of Antenatal Betamethasone on Plasma Glucose Levels". It is known that administration of steroids increases blood sugar levels. Administration of betamethasone is common practice during pregnancy to women at risk for preterm delivery. However, it is unknown the magnitude of the changes in glucose these women have after receiving betamethasone. The purp...
What is the current status of trial NCT00585676?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2007-11. Estimated completion is 2011-05.
Who is sponsoring clinical trial NCT00585676?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia